Two Targets, One Mission: Advancing Cancer Care With Bispecific Antibodies

Available until 3/12/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

Despite compelling evidence supporting the efficacy of bispecific antibodies in relapsed/refractory cancers, clinical adoption is hindered by knowledge gaps in mitigating and managing toxicities.

Smart Bombs in Cancer Care: Unlocking the Potential of Antibody-Drug Conjugates

Available until 3/19/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This practical guide will help bridge some of these gaps by providing key insights into the complex landscape of ADCs, including their mechanisms of action, clinical applications, and limitations.

Biosimilars Explained: An Indispensable Tool for Modern Oncology Practice

Available until 3/26/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This monograph provides a comprehensive overview of biosimilars in oncology, addressing key barriers to adoption and offering practical guidance for their implementation in clinical practice.

MICROLEARNING In for the Long Haul: Identifying and Managing Residual MDD Symptoms – Module 2

Available until 6/3/2026
0.25 CME credits available
Posted by QDCME on 6/6/2025

Learn anytime, anywhere with our 15-minute interactive microlearning activity—quick, engaging, and designed to fit your busy schedule!

MICROLEARNING In for the Long Haul: Identifying and Managing Residual MDD Symptoms – Module 1

Available until 6/3/2026
0.25 CME credits available
Posted by QDCME on 6/6/2025

Learn anytime, anywhere with our 15-minute interactive microlearning activity—quick, engaging, and designed to fit your busy schedule!

Collaborative Efforts in Early Detection and Intervention for Alzheimer’s Disease

Available until 1/14/2026
1.0 CME credit available
Posted by MLI Education on 6/4/2025

This program for family medicine & primary care clinicians who play a role in identifying and managing patients at risk of early Alzheimer’s disease (AD) and cognitive impairment.

Podcast: Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 4

Available until 2/16/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/4/2025

Expert faculty will bring together recent advances and clinical care into providing patient-centered care for schizophrenia.

Podcast: Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 3

Available until 2/16/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/4/2025

Expert faculty will discuss current and emerging treatments that reduce cognitive symptoms and enhance cognitive functioning, to improve overall functioning in patients with schizophrenia.

Podcast: Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 2

Available until 2/16/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/4/2025

In Module 2 of this podcast, expert faculty will provide insights into improving treatment adherence through the use of LAIs for schizophrenia.

Podcast: Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 1

Available until 2/16/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/4/2025

Expert faculty will discuss the shortcomings of available dopamine blocking agents to treat schizophrenia and ongoing efforts to optimize therapy.